Biogen Jumps on Gene Therapy Train with Nightstar Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 3 (Table of Contents)
Published: 12 Mar-2019
DOI: 10.3833/pdr.v2019.i3.2411 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a move to rebuild its ophthalmology pipeline, Biogen has acquired gene therapy specialist, Nightstar Therapeutics, for approximately US$877 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS